Lesch Nyhan Syndrome LNS
Document Sample


Lesch-Nyhan Syndrome (LNS)
By:
Amir Sadafi and
Bela Mohapatra
What is LNS?
LNS is a genetic disorder first discovered in
1964 by Michael Lesch and William Nyhan.
It is a recessive disease that is linked to the X
chromosome
It is caused by a deficiency of the enzyme
hypoxanthine-guanine
phosphoribosyltransferase (HPRT)
Symptoms of LNS
All of the following are a result of an overproduction of Uric Acid
Urate crystal formations, Athetosis (uncontrolled
which look like orange spastic muscle movements
sand, are deposited in of the arms and legs)
diapers of the babies Involuntary writhing
Kidney stones movements
Blood in the urine Chorea (purposeless
Dysphagia (difficulty repetitive movements)
swallowing) Moderate mental
Swelling of the joints retardation
Vomiting Irritability
Clinical Elements
Overproduction of Uric Acid
- associated with hyperuricernia
- can produce Nephrolithiasis (kidney stones) with renal failure
and solid subcutaneous deposits (tophi)
Neurological disability
- includes dystonia (abnormal firmness of tissue or muscle),
choreoathetosis (abnormal movement of body), and occasional
ballismus (jerky movement of arms or legs)
- other signs include spasticity and hyperreflexia
Behavioral Elements
- cognative disfunction and aggressive and impulsive behaviors
-severe self injurious behavior is common
HPRT’s role in the body
Hypoxanthine-guanine phosphoribosyltransferase is an
enzyme that plays a key role in the recycling of the
purine bases, hypoxanthine, and guanine into purine
nucleotide pools
Without HPRT the purine bases are broken down and
excreted as uric acid
Since these purine bases cannot be reused, the
production of purine bases is increased
Both of these together cause a significant overproduction
of uric acid
Hyperuricemia
Hyperuricemia is an unusually high concentration of uric
acid in the blood
Since the blood usually already has a high concentration of
uric acid, the increased uric acid solidifies and deposits in
the tissues forming tophi
The deposits in the joints cause inflammation and gouty
arthritis
The kidneys excrete the extra uric acid, which increases risk
of urate stones forming
The stones may pass as a sandy sludge or may obstruct
urine flow
This increases the risk for hematuria and urinary tract
infections
Statistics
Frequency:
-Reported prevalence is 1 per 380,000
Mortality:
-Few patients live beyond 40 years.
-The drug allopurinol is used to control
hyperuricernia. Most patients experience progressive
dysphagia (difficulty swallowing) and die after
pneumonia .
-Also common is sudden unexpected death, even to
patients in stable medical condition.
Race:
-LNS effects most races with equal frequency.
LNS and Cerebral Palsy
“Cerebral palsy is a group of movement
disorders that result from damage to the
brain, either before, during or shortly
after birth.”
Thus, LNS is often the cause of the
damage to the brain that triggers cerebral
palsy
Treatment and Prognosis
Treatment:
-LNS itself cannot be treated
-Only the symptoms of LNS can be treated.
-The drug allopurinol may be used to control excessive amounts of
uric acid.
-Kidney stones can be treated with lithotripsy
-There are unfortunately no treatments for the behavioral and
neurological effects of LNS
Prognosis:
-The prognosis for LNS is poor because there are no treatments for
the neurological effects of the syndrome.
-The build-up of excessive uric acid in the body causes painful
episodes of self-mutilation and may result in severe retardation
and death.
X-Linked Recessive Inheritance
Bibliography
http://www.guidinghands.org/faqs/cerebr
alpalsy.htm
http://www.emedicine.com/neuro/topic63
0.htm
http://www.ninds.nih.gov/disorders/lesch
_nyhan/lesch_nyhan.htm
http://depts.washington.edu/genetics/cou
rses/genet371b-
aut00/public_html/problems/371B_practic
e_key_02.html
Get documents about "